Meredith Marie Markey, PA-C

Meredith Markey practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Meredith Markey's NPI, 1629467063, was assigned on January 22, 2015. Meredith Markey graduated from Yale University School of Medicine in 2014.

Meredith Markey's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Meredith Markey also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Meredith Markey's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Meredith Markey to 1 more breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Meredith Markey practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Meredith Markey's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Meredith Markey is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Meredith Markey has a license on file in Florida.

Dmand AI lists fluid and electrolyte imbalances, neuropathy and upper respiratory infection (URI) among the conditions Meredith Markey treats.

CMS data shows 140 Medicare services from Meredith Markey across 2 procedure codes in 2024, for 53 Medicare patients. Medicare paid $5,722 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Meredith Markey in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Meredith Markey's median patient age at 56, with 85% women.

In 2024, Meredith Markey wrote 42 Medicare Part D claims for 22 patients. 93% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $353 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Meredith Markey for performance year 2024, reported as part of a group. Meredith Markey accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Meredith Markey as offering telehealth.

Meredith Markey graduated from Yale University School of Medicine in 2014.